Similar articles for PMID: 30814031

Year	Number of Results
2009	3
2010	3
2011	4
2012	13
2013	13
2014	9
2015	13
2016	14
2017	24
2018	13
2019	18
2020	16
2021	9
2022	8
2023	3
2024	0

1

Role of Platelet Transfusion in the Reversal of Anti-Platelet Therapy.

Nagalla S, Sarode R. Nagalla S, et al. Transfus Med Rev. 2019 Apr;33(2):92-97. doi: 10.1016/j.tmrv.2019.01.002. Epub 2019 Jan 25. Transfus Med Rev. 2019. PMID: 30814031 Review.

2

Oral antiplatelet therapy: impact for transfusion medicine.

Gremmel T, Panzer S. Gremmel T, et al. Vox Sang. 2017 Aug;112(6):511-517. doi: 10.1111/vox.12537. Epub 2017 May 30. Vox Sang. 2017. PMID: 28560760 Review.

3

Exploration of efficacy and bleeding with combined phosphoinositide 3-kinase β inhibition and aspirin in man.

Nylander S, Wågberg F, Andersson M, Skärby T, Gustafsson D. Nylander S, et al. J Thromb Haemost. 2015 Aug;13(8):1494-502. doi: 10.1111/jth.13027. Epub 2015 Jul 23. J Thromb Haemost. 2015. PMID: 26096765 Free article. Clinical Trial.

4

Effects of P2Y12 receptor inhibition with or without aspirin on hemostatic system activation: a randomized trial in healthy subjects.

Traby L, Kollars M, Kaider A, Eichinger S, Wolzt M, Kyrle PA. Traby L, et al. J Thromb Haemost. 2016 Feb;14(2):273-81. doi: 10.1111/jth.13216. Epub 2016 Jan 30. J Thromb Haemost. 2016. PMID: 26663880 Free article. Clinical Trial.

5

Reversibility of platelet P2Y12 inhibition by platelet supplementation: ex vivo and in vitro comparisons of prasugrel, clopidogrel and ticagrelor.

Bertling A, Fender AC, Schüngel L, Rumpf M, Mergemeier K, Geißler G, Sibrowski W, Kelsch R, Waltenberger J, Jakubowski JA, Kehrel BE. Bertling A, et al. J Thromb Haemost. 2018 Jun;16(6):1089-1098. doi: 10.1111/jth.14014. Epub 2018 Apr 23. J Thromb Haemost. 2018. PMID: 29582544 Free article.

6

Advocating cardiovascular precision medicine with P2Y12 receptor inhibitors.

Winter MP, Grove EL, De Caterina R, Gorog DA, Ahrens I, Geisler T, Gurbel PA, Tantry U, Navarese EP, Siller-Matula JM. Winter MP, et al. Eur Heart J Cardiovasc Pharmacother. 2017 Oct 1;3(4):221-234. doi: 10.1093/ehjcvp/pvw044. Eur Heart J Cardiovasc Pharmacother. 2017. PMID: 28204303 Review.

7

[Antiplatelet agents and transfusion].

Gaussem P, Martin AC, Belleville-Rolland T, Helley D, Bachelot-Loza C, Godier A. Gaussem P, et al. Transfus Clin Biol. 2017 Sep;24(3):160-165. doi: 10.1016/j.tracli.2017.05.014. Epub 2017 Jun 20. Transfus Clin Biol. 2017. PMID: 28645644 Review. French.

8

Clinical use of clopidogrel.

Sarafoff N, Byrne RA, Sibbing D. Sarafoff N, et al. Curr Pharm Des. 2012;18(33):5224-39. doi: 10.2174/138161212803251853. Curr Pharm Des. 2012. PMID: 22724411 Review.

9

Response variability to P2Y12 receptor inhibitors: expectations and reality.

Siller-Matula JM, Trenk D, Schrör K, Gawaz M, Kristensen SD, Storey RF, Huber K; EPA (European Platelet Academy). Siller-Matula JM, et al. JACC Cardiovasc Interv. 2013 Nov;6(11):1111-28. doi: 10.1016/j.jcin.2013.06.011. JACC Cardiovasc Interv. 2013. PMID: 24262612 Free article. Review.

10

Aspirin and P2Y12 Inhibitors in platelet-mediated activation of neutrophils and monocytes.

Schrottmaier WC, Kral JB, Badrnya S, Assinger A. Schrottmaier WC, et al. Thromb Haemost. 2015 Aug 31;114(3):478-89. doi: 10.1160/TH14-11-0943. Epub 2015 Apr 23. Thromb Haemost. 2015. PMID: 25904241 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

134 results

Results by year